Loopworm Secures $3.25M for Silkworm-Based Protein Production
Loopworm, a Bengaluru-based biotechnology startup, has secured $3.25 million in a pre-Series A funding round. The round was co-led by WaterBridge Ventures and ENRISSION INDIA CAPITAL, with participation from the company's previous seed investors.
Loopworm operates a state-of-the-art insect processing facility in Bengaluru, with a capacity of 6,000 tonnes per year, one of the largest in Asia. The company specialises in producing insect-derived proteins and lipids, which are used in aquafeed and pet nutrition across multiple continents.
The startup utilises silkworms as 'living bioreactors' to produce complex recombinant proteins. Its platform has successfully expressed antigens, growth factors, and other complex proteins within silkworm pupae. Loopworm's product portfolio includes insect-based soluble proteins, collagen, enzymes, and lipids.
This latest funding round follows a previous seed funding round of $3.4 million, led by Omnivore and other early backers. The Series A financing round was led by a prominent venture capital firm specialising in biotechnology investments.
The new capital will support the commercialisation of Loopworm's silkworm-based protein production platform. Loopworm plans to use the funding to scale production, expand R&D partnerships, and accelerate product time-to-market. With this investment, Loopworm is well-positioned to continue its growth and make a significant impact in the insect-based protein industry.
Read also:
- Setting Up and Expanding Operations at a Soil Blending Facility
- Surveying the Scene: Legality, Drones, and American Anti-Terror Strategy
- Regional University's healthcare system strengthened through collaborative partnership with Chancellor Dr Fiona Hill
- Reminisced University Trustee David M. Flaum as a 'fervent advocate' for the University and community
